Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies

Introduction: The clinical impact of invasive hemodynamic support with Impella in patients with cardiogenic shock (CS) remains to be defined.Methods: Only studies including patients treated with Impella in CS were selected. The primary endpoint was short term mortality, while secondary endpoints were major vascular complications and major bleeding.Results: 17 studies and 3933 patients were included in the analysis. Median age was 61.9 (IQR 59.2 –63.5) years, CS was mainly related to acute coronary syndrome (ACS): 79.6% (IQR 75.1–79.6).

Source: International Journal of Cardiology - September 20, 2020 Category: Cardiology Authors: Iannaccone Mario, Stefano Albani, Francesco Giannini, Salvatore Colangelo, Giacomo G. Boccuzzi, Garbo Roberto, Emmanouil S. Brilakis, D ’ascenzo Fabrizio, Gaetano Maria de Ferrari, Antonio Colombo Source Type: research